IST:MEDTR Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	2,094	2,097	1,596	375.93	359.32
Revenue Growth (YoY)	-0.11%	31.40%	324.48%	4.62%	-
Cost of Revenue	1,297	1,196	936.41	216.75	200.96
Gross Profit	796.94	900.69	659.33	159.18	158.36
Selling, General & Admin	479.31	423.05	241.54	66.76	63.56
Research & Development	23.14	20.07	6.54	2.45	0.84
Other Operating Expenses	61.98	79.02	25.38	0.88	-7.09
Operating Expenses	564.43	522.14	273.46	70.09	57.32
Operating Income	232.51	378.55	385.87	89.09	101.04
Interest Expense	-73.77	-76.1	-39.68	-13.37	-7.78
Interest & Investment Income	64.08	220.51	48.87	19.44	6.49
Earnings From Equity Investments	-12.35	-10.49	-1.97	-0.5	-1.13
Currency Exchange Gain (Loss)	102.15	162.13	190.45	107.6	-10.14
Other Non Operating Income (Expenses)	-237.79	-594.35	-387.57	-0.16	0.23
EBT Excluding Unusual Items	74.84	80.26	195.96	202.1	88.72
Gain (Loss) on Sale of Investments	-2.24	-	-	-	-1.91
Other Unusual Items	-	-	-	-	-21.73
Pretax Income	72.6	80.26	195.96	202.1	65.08
Income Tax Expense	2.28	42.85	81.66	34.4	4.65
Earnings From Continuing Operations	70.32	37.41	114.3	167.7	60.43
Minority Interest in Earnings	3.1	-0.06	0.03	-	-
Net Income	73.43	37.35	114.34	167.7	60.43
Net Income to Common	73.43	37.35	114.34	167.7	60.43
Net Income Growth	96.63%	-67.34%	-31.82%	177.53%	-
Shares Outstanding (Basic)	119	119	119	119	95
Shares Outstanding (Diluted)	119	119	119	119	95
Shares Change (YoY)	-	-	-	25.93%	-
EPS (Basic)	0.62	0.31	0.96	1.41	0.64
EPS (Diluted)	0.62	0.31	0.96	1.41	0.64
EPS Growth	99.05%	-67.71%	-31.85%	120.30%	-
Free Cash Flow	404.72	501.46	-43.66	27.72	52.41
Free Cash Flow Per Share	3.40	4.21	-0.37	0.23	0.56
Dividend Per Share	-	0.294	-	-	-
Gross Margin	38.05%	42.96%	41.32%	42.34%	44.07%
Operating Margin	11.10%	18.05%	24.18%	23.70%	28.12%
Profit Margin	3.51%	1.78%	7.17%	44.61%	16.82%
Free Cash Flow Margin	19.32%	23.92%	-2.74%	7.38%	14.59%
EBITDA	319.52	448.77	431.95	100.13	112.23
EBITDA Margin	15.26%	21.40%	27.07%	26.63%	31.23%
D&A For EBITDA	87.01	70.22	46.08	11.04	11.19
EBIT	232.51	378.55	385.87	89.09	101.04
EBIT Margin	11.10%	18.05%	24.18%	23.70%	28.12%
Effective Tax Rate	3.14%	53.39%	41.67%	17.02%	7.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.